文献速递腹部外周血管CTMRUS

肾动脉狭窄CT评估的狭窄后扩张与肾脏MCP-1释放相关

Association between CT-evaluated Poststenotic Dilatation in Human Renal Artery Stenosis and Kidney Release of MCP-1.
PubMed 文献 · Radiology · 2026-01-01

研究纳入49例肾动脉狭窄患者,在三维多排腹部CT上测量狭窄后扩张(PSD)的扩张直径比(DDR),并分析其与狭窄侧肾脏静脉炎症因子水平的关系。结果显示DDR与肾脏静脉MCP-1水平独立正相关,PSD患者皮质体积更低,且PTRA后PSD回缩程度与MCP-1水平负相关。

要点

  • 腹部CT测量DDR可用于评估肾动脉狭窄后扩张程度。
  • DDR越高,狭窄侧肾静脉MCP-1水平越高,提示肾损伤。
  • PSD患者狭窄侧肾皮质体积中位数更低,需在报告中关注肾实质体积变化。

关键影像表现/征象

  • PSD患者(n=31)与无PSD患者(n=18)年龄、血压、实测GFR和狭窄侧肾氧合可比,但PSD患者狭窄侧肾皮质体积中位数更低。
  • DDR与狭窄侧肾静脉中性粒细胞明胶酶相关脂质运载蛋白、干扰素-γ和MCP-1水平正相关(均P<.05),这些因子在PSD患者中较无PSD患者升高,且在狭窄侧肾静脉较下腔静脉升高。
  • DDR与尿蛋白水平正相关(r=0.33,P=.04),与估算GFR负相关(r=-0.51,P=.004)。
  • DDR与肾脏血流动力学、动脉形态特征或多普勒超声血流速度无明确相关证据。
  • PTRA未改善估算GFR,但诱导PSD回缩,回缩程度与狭窄侧肾静脉MCP-1水平负相关。

诊断标准与关键数值

  • 扩张直径比(DDR)为CT测量的狭窄后扩张指标,DDR与狭窄侧肾静脉MCP-1水平的未调整回归系数为0.813(95%CI:0.328,1.298;P=.002),多变量调整后为0.889(95%CI:0.246,1.532;P=.009),即MCP-1每升高1 ng/mL,DDR独立增加0.889单位。

临床应用与阅片要点

  • 阅片时可在腹部CT报告中描述肾动脉狭窄后扩张的存在及DDR,作为肾损伤的影像标志。
  • PSD患者应关注狭窄侧肾皮质体积是否减低,提示肾实质损伤。
  • DDR与多普勒超声血流速度无相关,不能以超声血流速度替代CT评估PSD。

局限性

  • 样本量较小(49例),仅7例接受PTRA,PTRA相关结论证据有限。
  • 研究为单中心前瞻性观察性设计,PSD与MCP-1的因果关系不能确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Renal artery stenosis (RAS) can trigger the development of renal damage and poststenotic dilatation (PSD). However, the clinical relevance and mechanisms are ill-characterized. Purpose To characterize the mechanisms underlying PSD development distal to the site of RAS in humans. Materials and Methods Forty-nine individuals with RAS were prospectively consecutively recruited from October 2013 to September 2024. The characteristics of the stenosis, including the dilatation-diameter ratio (DDR), and single-kidney volumes, perfusion, and glomerular filtration rate (GFR) were measured at three-dimensional multidetector abdominal CT. Additional characteristics included stenotic kidney (STK) oxygenation (blood oxygen level-dependent MRI), cytokine levels in the STK renal vein (RV) and inferior vena cava (blood sampling), and measured GFR (iothalamate clearance). Seven participants subsequently underwent percutaneous transluminal renal angioplasty (PTRA). Data were analyzed with Spearman correlation and linear regression. Results Of 49 participants with RAS (median age, 73 years [IQR, 67-75 years]; 28 male participants), age, blood pressure, measured GFR, and STK oxygenation were comparable between participants with PSD (n = 31) and participants without PSD (n = 18), but participants with PSD had a lower median STK cortical volume. DDR positively correlated with the STK RV levels of neutrophil gelatinase-associated lipocalin, interferon-γ, and monocyte chemoattractant protein-1 (MCP-1), which were elevated in participants with PSD versus participants without PSD or in the STK RV versus the IVC (all P < .05). The regression coefficient between STK RV MCP-1 level and DDR was 0.813 (95% CI: 0.328, 1.298; P = .002) in an unadjusted model and 0.889 (95% CI: 0.246, 1.532; P = .009) after multivariable adjustment for potential confounders; that is, each 1-ng/mL increase in STK RV MCP-1 level was independently associated with a 0.889-unit DDR increase. DDR also correlated positively with urinary protein level (r = 0.33; P = .04) and negatively with estimated GFR (r = -0.51; P = .004), but there was no evidence of a correlation of DDR with renal hemodynamics, arterial morphologic features, or blood flow velocity at Doppler US. PTRA did not improve estimated GFR but did induce PSD regression, the extent of which correlated negatively with STK RV MCP-1 level. Conclusion PSD, as evaluated at abdominal CT, may be associated with STK damage and the release of MCP-1. Clinical trial registration nos. NCT02266394 and NCT04508049 © RSNA, 2026 Supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Al Saeedi M, Abdurakhimova DA, Arabi T, et al. Association between CT-evaluated Poststenotic Dilatation in Human Renal Artery Stenosis and Kidney Release of MCP-1. Radiology. 2026. PMID: 42048594. doi:10.1148/radiol.252637

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。